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Abstract
Background: The obese-asthma phenotype is not well defined. The aim of this study was to examine both
mechanical and inflammatory influences, by comparing lung function with body composition and airway
inflammation in overweight and obese asthma.
Methods: Overweight and obese (BMI 28-40 kg/m
2) adults with asthma (n = 44) completed lung function
assessment and underwent full-body dual energy x-ray absorptiometry. Venous blood samples and induced
sputum were analysed for inflammatory markers.
Results: In females, android and thoracic fat tissue and total body lean tissue were inversely correlated with
expiratory reserve volume (ERV). Conversely in males, fat tissue was not correlated with lung function, however
there was a positive association between android and thoracic lean tissue and ERV. Lower body (gynoid and leg)
lean tissue was positively associated with sputum %neutrophils in females, while leptin was positively associated
with android and thoracic fat tissue in males.
Conclusions: This study suggests that both body composition and inflammation independently affect lung
function, with distinct differences between males and females. Lean tissue exacerbates the obese-asthma
phenotype in females and the mechanism responsible for this finding warrants further investigation.
Keywords: adipose tissue, dual energy x-ray absorptiometry, leptin, lung volume measurements, neutrophil,
physiology
Background
Obesity and asthma are associated conditions, with
obese asthmatics experiencing more severe asthma
symptoms, reduced lung function and poorer asthma-
related quality of life, compared to asthmatics of a
healthy weight [1,2]. Although these clinical characteris-
tics are well described, the mechanisms responsible are
not understood. The most recent evidence suggests that
the obese-asthma phenotype has both mechanical [3]
and inflammatory [4,5] influences, and that these differ
between males and females. Excess adipose tissue exerts
a mechanical effect on the lungs, whereby fat tissue
within the android (abdominal) region reduces the capa-
city of the diaphragm to shift downward thereby limit-
ing lung inflation [3]. Fat tissue in the thoracic region
reduces chest cavity volume and diminishes chest wall
movement [3]. Body composition and fat distribution
differ between males and females, which may account
for some of the sex differences observed in lung
mechanics [6].
The effect of obesity-induced inflammation has also
been investigated in asthma and it appears to be sexu-
ally dimorphic in nature. We recently reported an
increase in neutrophilic airway inflammation in obese
asthmatic females compared with non-obese asthmatic
females; an observation that was not apparent in males
[4]. In addition, previous authors have cited a relation-
ship between asthma incidence and serum leptin in
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levels and poorer lung function [7].
A number of studies have examined the relationship
between BMI and respiratory function impairment, with
an association cited by some [8], but not all [9,10]
authors. These discrepancies are likely due to BMI
being a crude marker of obesity that does not account
for either the quantity or distribution of fat and lean tis-
sue. This is a critical issue because both adipose and
lean tissue exert contrasting mechanical and inflamma-
tory effects. Regional adiposity estimated by skinfold
thickness and waist circumference measurement appears
to be more consistently related to lung function impair-
ment, particularly within the android and thoracic
regions [9,11-13]. However, the sensitivity and reliability
of skinfold thickness measurement has been questioned,
particularly in obese subjects [14-16] and neither mea-
sure accounts for lean tissue. Dual-energy x-ray absorp-
tiometry (DXA) however provides a reliable and
superior measurement of body composition by quantify-
ing regional fat and lean tissue (muscle) mass.
The combined mechanical and inflammatory influ-
ences of obesity on respiratory function in asthma are
not well understood. Therefore, we sought to examine
this association within an asthmatic population. We
hypothesised that both android and thoracic fat mass
and lean mass directly impacts lung function via
mechanical influences. We also hypothesised that body
composition affects both systemic inflammation and air-
way inflammation, altering lung function and asthma
status independent of these mechanical influences. The
aim of this study was to investigate the relationships
between lung function and body composition, systemic
inflammation and airway inflammation in overweight
and obese males and females with asthma. Further, we
sought to examine sex-specific differences in these
relationships.
Methods
Subjects
Non-smoking overweight and obese (BMI 28-40 kg/m
2)
males (n = 20) and females (n = 24) with asthma were
recruited from John Hunter Hospital, NSW, Australia,
prior to commencement in a weight loss intervention.
Asthma was defined by doctor’s diagnosis and airway
hyperresponsiveness to hypertonic saline. Medical
records were examined for documented history of air-
way hyperresponsiveness; in instances where this was
not recorded, participants underwent hypertonic saline
challenge prior to admission into the study. All subjects
were classified as stable with no asthma exacerbation,
respiratory tract infection or oral corticosteroid use in
the preceding four weeks. Subjects underwent skin
allergy testing and completed the Asthma Control Ques-
tionnaire (ACQ) [17]. This research was approved by
the Hunter New England Human Research Ethics Com-
mittee and all subjects provided written informed
consent.
Lung Function Tests
Dynamic lung function [forced expiratory volume in one
second (FEV1) and forced vital capacity (FVC)] was
measured using a KoKo spirometer (POS Instrumenta-
tion, Inc, Louisville USA), while static lung function
[total lung capacity (TLC), functional residual capacity
(FRC) and expiratory reserve volume (ERV)] was mea-
sured using a computerised plethysmograph system
(Vmax Encore, Sensormedics Corp., Yorba Linda, Ca,
USA). These measurements were conducted in accor-
dance with ATS/ERS guidelines [18,19].
Anthropometric Measurements
Body weight was determined using calibrated electronic
scales (Nuweigh LOG 842, NWS, Newcastle Australia),
while participants wore light clothing and no shoes.
Height was measured using a wall-mounted stadiometer.
Waist circumference was measured using an inelastic
tape (Lufkin W606PM Executive Diameter Tape 2 m ×
6 mm, Lufkin USA), at the midpoint of the lowest rib
and iliac crest [16]. Both height and waist circumference
were measured in duplicate, with measurements within
5 mm for height and 10 mm for waist circumference
deemed acceptable. All subjects were classified as weight
stable, defined as weight maintenance within 5% for the
preceding three months.
A total body scan was performed by DXA (Lunar
Prodigy Series, GE Medical Systems, Madison USA).
Subjects wore light clothing, no shoes and removed
unfixed metal objects. Lean mass and fat mass were
measured in grams, with %fat calculated as [fat mass/
(lean mass+fat mass) × 100]. The android region was
defined as extending from the pelvis to 20% of the dis-
tance between the neck and pelvis, with the gynoid
region extending from 1.5 times the height of the
android region inferior to the pelvis and had a height
double that of the android region [20]. The thoracic
region was defined as the superior segment of the
trunk region bisecting at the most infero-lateral limit
o ft h er i bc a g e[ 6 ] .A r mr e g i o n sp a s s e dt h r o u g ht h e
arm sockets, while leg regions passed through the hip
s o c k e t s[ 2 0 ] .D X Ah a sb e e ns h o w np r e v i o u s l yt op r o -
vide a reliable and accurate measure of both adipose
and lean tissue, with a precision error of 1.5% for lean
mass and < 1.5% for fat mass [21]. Quality assurance
and quality control measures were performed daily in
accordance with the manufacturer’si n s t r u c t i o n s .
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Sputum induction coupled with bronchial provocation
using 4.5% hypertonic saline was performed over a stan-
dardised 15.5 minutes nebuliser time [22]. A decrease in
FEV1 ≥ 15% from baseline was indicative of airway
hyperresponsivensss. Provocation dose (PD15) was cal-
culated and b2-agonist (salbutamol 200 μg) was adminis-
tered [22]. Lower respiratory sputum portions were
selected and dispersed using dithiothreitol. Total cell
counts and cell viability (trypan blue exclusion) were
determined by haemocytometer. Differential cell counts
were determined from cytospins, which were prepared,
s t a i n e d( M a y - G r u n w a l dG e i m s a )a n dc o u n t e df r o m4 0 0
non-squamous cells. Absolute cell counts were calcu-
lated in a standardised manner. For example, absolute
sputum neutrophils were calculated as [(%Neutrophils/
100) × Total Cell Count] × 1000, where the total cell
count is expressed as × 10
6 cells/mL.
Serum Inflammatory Markers
Venous blood was collected after a 12-hour overnight
fast. C-reactive protein (CRP) was measured in hepari-
nised plasma using the CRP Flex
® reagent cartridge
(Siemens Healthcare Diagnostics Inc., Newark USA) and
automatically analysed by the Dimension Vista
® System
(Siemens Healthcare Diagnostics Inc., Newark USA).
The limit of quantitation was 2.9 mg/L. For samples
below this limit, additional heparinised plasma was pro-
cessed using the CRP Extended Range method [23] with
results automatically determined using the Dimension
®
System (Siemens Healthcare Diagnostics Inc., Newark
USA). The analytical sensitivity of this method was 0.5
mg/L. A commercial multiplex assay was used to mea-
sure serum leptin (Bio-Rad, Hercules CA USA), with a
sensitivity of 2.3 pg/mL.
Statistical Analysis
Data were analysed using a statistical software package
(Intercooled Stata version 11.1, Stata Corporation, Col-
lege Station TX USA) and are reported as median (inter-
quartile range), mean ± standard deviation or % the
percentage of subjects with the specified variable. Contin-
uous data were compared by sex using the Kruskal-
Wallis test with post-hoc Wilcoxon rank sum testing or
ANOVA with post-hoc two sample t-testing. Sex-specific
associations between lung function and systemic inflam-
mation, airway inflammation and body composition were
determined by partial correlations adjusted for height,
age and pack years. Non-parametric variables were trans-
formed. Sex-stratified backward and forward stepwise
regression was used to verify the independent effects of
both central body composition (android and gynoid) and
inflammation on ERV and FEV1/FVC, until the most par-
simonious model was achieved. Due to android and
thoracic mass being highly correlated, thoracic lean mass
and fat mass were not entered into the regression mod-
els. Models including ERV (litres) were adjusted for
height and age, and all multivariate models were age-
adjusted. P-values ≤0.2 entered the multivariate model.
P-values ≤0.05 were considered statistically significant.
Results
Subject Characteristics
Characteristics of the 44 subjects are presented in Table
1. Males and females were of a similar age, however
Table 1 Subject Characteristics.
Males Females
N (%) 20 (45.5) 24 (54.5)
Age (years) 40.8 ± 11.4 38.8 ± 14.9
BMI (kg/m
2) 32.2 ± 2.9 35.1 ± 3.6**
Waist Circumference (cm) 113.0 ± 10.1 107.8 ± 9.6
Total Body Fat (%) 35.2 ± 5.0 50.3 ± 3.8***
Android Fat (%) 46.2 (41.6, 51.5) 55.8 (52.7, 59.9)***
Gynoid Fat (%) 37.0 ± 4.6 55.6 ± 3.9***
Thoracic Fat (%) 35.4 ± 5.1 45.9 ± 4.9***
FEV1 %predicted 79.3 ± 19.5 83.3 ± 17.5
FVC %predicted 96.7 (84.0, 98.8) 96.4 (85.8, 107.9)
FEV1/FVC 66.5 (58.2, 78.9) 73.7 (67.1, 78.4)
TLC %predicted 98.1 ± 13.6 97.6 ± 12.0
FRC %predicted 101.5 ± 27.5 89.8 ± 19.0
ERV %predicted 112.2 (87.3, 130.4) 110.1 (93.3, 127.4)
Atopy (%) 100.0 78.3*
ICS Dose (μg/day) † 1000 (0, 1250) 1000 (0, 1000)
ICS Use (%) 70.0 70.8
Ever Smokers (%) 35.0 33.3
Pack Years of Ever Smokers 8 (1, 15) 3 (1, 7)
Age at Asthma Diagnosis (Years) 6 (2, 16) 8 (3, 18)
ACQ Score 1.2 ± 0.7 1.4 ± 0.5
GINA Classification (%)
Intermittent 25.0 12.5
Mild Persistent 20.0 29.2
Moderate Persistent 30.0 45.8
Severe Persistent 25.0 12.5
Systemic Inflammatory Markers
Leptin (μg/L) 6.2 (4.4, 10.9) 28.4 (19.7, 33.4)***
C-Reactive Protein (mg/L) 1.6 (0.9, 5.0) 4.8 (2.8, 8.3)**
Airway Inflammatory Markers
Total Cell Count (× 10
6/mL) 2.6 (2.1, 4.1) 2.0 (1.4, 5.6)
Neutrophils (%) 31.3 ± 19.8 35.5 ± 24.9
Neutrophils (× 10
4/mL) 752 (321, 1641) 1051 (277, 2709)
Eosinophils (%) 4.3 (2.2, 10.3) 1.3 (0.5, 3.3)*
Eosinophils (× 10
4/mL) 184 (68, 375) 100 (11, 133)*
Data presented as mean ± standard deviation, median (IQR) or % the
percentage of subjects with the specified variable. BMI - body mass index;
FEV1 - forced expiratory volume in one second; FVC - forced vital capacity;
TLC - total lung capacity; FRC - functional residual capacity; ERV - expiratory
reserve volume. * p≤0.05 versus males; ** p≤0.01 versus males; *** p≤0.001
versus males; † Beclomethasone equivalents.
Scott et al. Respiratory Research 2012, 13:10
http://respiratory-research.com/content/13/1/10
Page 3 of 10females had a significantly higher BMI (p =0 . 0 0 6 )a n d
total and regional %body fat (p < 0.001). %Predicted
lung function, age of asthma onset and steroid use were
similar between the sexes. Males had a higher eosinophil
concentration in the sputum and a significantly greater
proportion were atopic (Table 1).
Body Composition and Lung Function
There were strong inverse correlations between waist
circumference and static lung function and FVC in
females (Table 2). There were also strong inverse corre-
lations between both ERV and FRC versus android fat
mass, thoracic fat mass and arm fat mass (Table 2).
There was also an inverse association between FEV1 and
FVC with arm fat mass in females. Of all the body com-
position measurements, only %fat and total fat mass of
the arms correlated with FEV1 in females. There was no
association between waist circumference or fat mass
with lung function in males (Table 2).
Although fat mass was not significantly associated with
lung function in males, lean mass had a significant positive
relationship. Android lean mass was positively associated
with static lung function, with ERV also positively
associated with thoracic and gynoid lean mass (Table 2).
These associations did not reach significance for dynamic
lung function measures (Table 3). Conversely, a negative
correlation between lean mass and lung function was
observed in females. Total body lean mass was inversely
associated with ERV, while arm lean mass was inversely
associated with ERV, TLC and FVC (Tables 2 and 3).
Body Composition, Systemic and Airway Inflammation
Fat mass, weight and waist circumference were posi-
tively associated with serum leptin in males, while
plasma CRP was negatively associated with leg lean
mass (Table 4). In females, both sputum %neutrophils
and absolute neutrophil count were positively associated
with lower body (gynoid and leg) lean mass (Table 5).
Interestingly, no association was observed between neu-
trophils and fat mass in males (Table 5). Also there was
also no significant association between systemic inflam-
mation and fat mass in females (Table 5). However,
gynoid fat mass was associated with a lower concentra-
tion of airway eosinophils and a lower provocation fall
after hypertonic saline challenge (dose response slope)
in females (Table 5).
Table 2 Relationship between body composition and static lung function measurements in males and females with
asthma.
Males Females
TLC (L) FRC (L) ERV (L) TLC (L) FRC (L) ERV (L)
Weight (kg) 0.034 0.157 0.482 -0.354 -0.516* -0.532*
Waist Circumference (cm) -0.125 0.086 0.494 -0.439* -0.479* -0.469*
Fat Mass (g)
Total -0.424 -0.208 0.257 -0.396 -0.506* -0.400
Android -0.434 -0.137 0.263 -0.275 -0.457* -0.505*
Gynoid -0.134 -0.132 0.456 -0.087 -0.285 -0.046
Thoracic -0.378 -0.130 0.319 -0.270 -0.488* -0.564**
Arms -0.341 -0.250 0.207 -0.719*** -0.562** -0.579**
Legs -0.040 -0.098 0.267 -0.202 -0.299 -0.047
Lean Mass (g)
Total 0.561* 0.409 0.164 -0.157 -0.261 -0.463*
Android 0.566* 0.670** 0.666** -0.038 -0.142 -0.375
Gynoid 0.383 0.406 0.531* -0.019 -0.211 -0.360
Thoracic 0.460 0.441 0.540* -0.057 -0.198 -0.401
Arms 0.497* 0.498* 0.040 -0.501* -0.367 -0.441*
Legs 0.523* 0.227 -0.157 -0.195 -0.257 -0.323
%Fat
Total -0.563* -0.322 0.180 -0.298 -0.319 -0.070
Android -0.691** -0.419 -0.007 -0.332 -0.473* -0.321
Gynoid -0.257 -0.280 0.331 -0.077 -0.149 0.141
Thoracic -0.610* -0.337 0.079 -0.265 -0.401 -0.350
Arms -0.445 -0.250 0.181 -0.595** -0.484* -0.460*
Legs -0.201 -0.177 0.325 -0.090 -0.138 0.130
Partial correlations are adjusted for height, age and pack years. TLC - logarithmic total lung capacity; FRC - logarithmic functional residual capacity; ERV -
expiratory reserve volume. * p≤0.05; ** p≤0.01; *** p≤0.001
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In a multiple linear regression model, ERV was posi-
tively associated with android lean mass in males (Table
6) but not females (Table 7). For every 100 g increase in
android lean mass in males, there was a corresponding
increase in ERV of 29 mL. Android fat mass was nega-
tively associated with ERV in females (Table 7) but not
males (Table 6), whereby every 100 g increase in
android fat mass resulted in a decrease in ERV of 20
mL. Inflammation was a more important predictor of
dynamic lung function, as there was a negative relation-
ship between FEV1/FVC and sputum %eosinophils in
males (Table 6) and sputum %neutrophils in females
(Table 7). For every 1% increase in sputum %eosinophils
in males and 5% increase is sputum %neutrophils in
females, there was a corresponding decrease in FEV1/
FVC of 0.6%.
Discussion
This study examined the association of lung function
with body composition and systemic and airway inflam-
mation, in overweight and obese males and females with
asthma. The findings of this study demonstrate a nega-
tive mechanical effect of adipose tissue on lung function
within both the android and thoracic regions, with this
relationship being particularly evident in females. Inter-
estingly, while lean mass within the android and thor-
acic regions was associated with improved lung function
in males, it had a negative or neutral effect in females.
Furthermore, the mechanical effect of obesity appears to
have a more significant impact on static lung function,
whereas both systemic and airway inflammation have
greater impact on dynamic lung function. We also
found neutrophilic airway inflammation was positively
associated with gynoid and leg lean mass but not fat
mass in females.
In females, we found that for every 100 g decrease in
android fat mass there was a corresponding increase in
ERV of 20 mL. This indicates that central fat mass
reduction is an important mechanism for improving
static lung function in females. However the inflamma-
tory influences we observed indicate that the relation-
ship between respiratory function and obesity in
females is more complex. The inflammatory effect of
obesity on lung function is occurring via innate
Table 3 Relationship between body composition and dynamic lung function measurements in males and females with
asthma.
Males (n = 19) Females (n = 24)
FEV1 (L) FVC (L) FEV1/FVC (L) FEV1 (L) FVC (L) FEV1/FVC (L)
Weight (kg) 0.035 0.030 0.057 -0.239 -0.402 0.140
Waist Circumference (cm) -0.007 -0.077 0.102 -0.399 -0.569** 0.019
Fat Mass (g)
Total 0.028 -0.101 0.164 -0.192 -0.349 0.181
Android -0.018 -0.187 0.162 -0.155 -0.330 0.163
Gynoid 0.081 -0.028 0.145 0.148 0.090 0.255
Thoracic -0.014 -0.128 0.119 -0.119 -0.323 0.219
Arms -0.092 -0.172 0.038 -0.535* -0.753*** 0.046
Legs 0.074 0.096 0.119 -0.097 -0.123 0.076
Lean Mass (g)
Total 0.296 0.461 0.059 -0.255 -0.333 -0.048
Android -0.165 -0.098 -0.361 -0.229 -0.259 -0.100
Gynoid 0.124 0.244 0.026 -0.063 -0.128 0.050
Thoracic 0.169 0.397 -0.067 -0.186 -0.271 -0.011
Arms -0.283 -0.137 -0.342 -0.341 -0.501* 0.011
Legs 0.377 0.498 0.143 -0.314 -0.350 -0.130
%Fat
Total -0.099 -0.270 0.122 0.000 -0.101 0.227
Android 0.051 -0.246 0.333 0.016 -0.191 0.318
Gynoid 0.003 -0.077 0.115 0.171 0.162 0.210
Thoracic -0.134 -0.368 0.147 0.035 -0.140 0.278
Arms 0.122 -0.002 0.224 -0.481* -0.651*** 0.036
Legs -0.071 -0.076 0.006 0.061 0.082 0.118
Partial correlations are adjusted for height, age and pack years. FEV1 - Forced expiratory volume in one second; FVC - forced vital capacity. * p≤0.05; ** p≤0.01;
*** p≤0.001.
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tion between sputum neutrophils, and lean mass, as
well as lung function. This is in agreement with other
authors, who show that it is not airway eosinophilia
driving the association between obesity and asthma
[24-27]. This also supports our previous study, where
we observed a positive association between sputum
neutrophils and BMI in asthmatic females [4]. While
other authors have reported no significant association
between obesity and neutrophilic airway inflammation,
they do illustrate a clear trend of increasing %neutro-
phils as BMI category increases [25-27]. The lack of
statistical significance in these studies may possibly be
due to sex effects not being examined [25,27], the
small sample size enrolled [25,26] and the high varia-
bility in the measurement of sputum neutrophils.
Interestingly, the positive relationship we observed in
this study was between neutrophilic airway inflamma-
tion and lean mass, but not fat mass. Sood et al [28]
previously observed a positive association between
asthma incidence and lean mass in 1422 females who
underwent body composition analysis using DXA. The
authors found that asthma incidence was more
strongly associated with lean mass than fat mass. The
authors hypothesised that this may be due to intra-
myocellular lipid; that is, fat droplets within skeletal
muscle that are highly metabolically active [28]. Intra-
myocellular lipid levels are higher in females and are
highly correlated with circulating leptin and adiponec-
tin levels [29,30]. Therefore, although lean tissue itself
is not proinflammatory, the presence of elevated intra-
myocellular lipid within lean tissue may exert proin-
flammatory effects. Interestingly, the association we
observed was between airway neutrophils and lower
body lean tissue. This observation suggests that the
relationship may be mediated by leptin. Leptin is
secreted 2-3 fold higher from subcutaneous compared
with visceral adipose tissue [31] and increases activa-
tion of neutrophils via TNF-a [32]. This may explain
the negative association we observed between respira-
tory function and lean tissue, the positive association
between sputum neutrophils and lower body lean tis-
sue and the positive trend between leptin and lower
body lean tissue in females. DXA scanning cannot dis-
tinguish intramyocellular lipid from lean tissue, hence
additional analysis would be required to test this
Table 4 Relationship between body composition and systemic inflammation (leptin, CRP), airway inflammation and
airway hyperresponsiveness in males.
Leptin (pg/
mL)
CRP (pg/
mL)
Neutrophils
(%)
Neutrophils (×
10
4/mL)
Eosinophils
(%)
Eosinophils (×
10
4/mL)
Dose Response
Slope †
Weight (kg) 0.533* 0.139 -0.200 -0.145 0.349 0.090 -0.198
Waist Circumference
(cm)
0.608* 0.217 -0.177 -0.097 0.433 0.118 -0.220
Fat Mass (g)
Total 0.749** 0.406 -0.160 -0.039 0.382 0.107 -0.192
Android 0.726** 0.409 -0.225 -0.038 0.380 0.052 -0.272
Gynoid 0.499 0.232 -0.106 -0.230 0.294 -0.053 -0.213
Thoracic 0.675** 0.400 -0.232 -0.195 0.434 0.059 -0.305
Arms 0.597* 0.444 -0.017 -0.064 0.538* 0.228 -0.162
Legs 0.402 0.235 -0.096 -0.060 0.239 0.099 -0.077
Lean Mass (g)
Total -0.120 -0.407 0.033 0.244 -0.062 0.225 -0.120
Android 0.333 0.005 -0.301 -0.029 0.344 0.379 0.242
Gynoid 0.084 -0.256 -0.242 -0.225 0.405 0.218 -0.223
Thoracic 0.051 -0.173 -0.258 -0.158 0.298 0.261 -0.206
Arms -0.462 -0.136 -0.252 -0.186 -0.110 -0.020 0.027
Legs -0.344 -0.604* 0.186 0.265 -0.395 0.005 -0.078
%Fat
Total 0.735** 0.502* -0.220 -0.166 0.465 0.071 -0.137
Android 0.634* 0.407 -0.134 -0.090 0.267 -0.095 -0.395
Gynoid 0.507 0.346 -0.100 -0.255 0.311 -0.088 -0.109
Thoracic 0.681** 0.511* -0.182 -0.182 0.416 -0.011 -0.248
Arms 0.658** 0.377 0.112 0.027 0.354 0.093 -0.246
Legs 0.498 0.439 -0.180 -0.192 0.418 0.103 -0.027
CRP - C-reactive protein. Partial correlations are adjusted for height, age and pack years. * p≤0.05; ** p≤0.01; *** p≤0.001. † Provocation fall (%) ÷ provocation
dose of 4.5% hypertonic saline (mL), after hypertonic saline challenge.
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airway hyperresponsiveness in females.
Leptin (pg/
mL)
CRP (pg/
mL)
Neutrophils
(%)
Neutrophils (×
10
4/mL)
Eosinophils
(%)
Eosinophils (×
10
4/mL)
Dose Response
Slope †
Weight (kg) 0.391 0.199 0.218 0.263 -0.370 -0.291 -0.196
Waist Circumference
(cm)
0.349 0.048 0.285 0.306 -0.125 -0.229 -0.045
Fat Mass (g)
Total 0.415 0.211 -0.040 -0.072 -0.506* -0.385 -0.270
Android 0.260 0.240 0.029 0.068 -0.333 -0.315 -0.113
Gynoid 0.316 0.168 -0.115 0.032 -0.650** -0.298 -0.480*
Thoracic 0.244 0.156 0.017 0.011 -0.413 -0.459 -0.209
Arms 0.317 0.036 0.026 -0.015 -0.031 -0.209 0.021
Legs 0.315 0.067 0.044 0.199 -0.438 -0.129 -0.362
Lean Mass (g)
Total 0.288 0.225 0.461 0.408 -0.048 -0.109 -0.060
Android 0.205 0.243 0.322 0.279 -0.042 -0.115 -0.122
Gynoid 0.232 0.247 0.544* 0.555* -0.159 -0.038 -0.125
Thoracic 0.193 0.180 0.323 0.273 -0.149 -0.227 -0.127
Arms 0.277 0.111 0.227 0.171 -0.077 -0.231 0.270
Legs 0.309 0.045 0.709*** 0.696** 0.070 0.119 0.087
%Fat
Total 0.216 0.110 -0.474* -0.349 -0.448 -0.324 -0.296
Android 0.166 0.112 -0.298 -0.205 -0.353 -0.263 -0.050
Gynoid 0.188 0.103 -0.441 -0.337 -0.512* -0.279 -0.451*
Thoracic 0.082 0.072 -0.306 -0.287 -0.334 -0.340 -0.133
Arms 0.317 -0.015 -0.076 -0.087 0.017 -0.094 -0.146
Legs 0.147 0.095 -0.345 -0.231 -0.445 -0.251 -0.420
CRP - C-reactive protein. Partial correlations are adjusted for height, age and pack years. * p≤0.05; ** p≤0.01; *** p≤0.001. † Provocation fall (%) ÷ provocation
dose of 4.5% hypertonic saline (mL), after hypertonic saline challenge.
Table 6 Multiple linear regression examining the relationship of body composition, airway inflammation and systemic
inflammation, with lung function in males.
ERV (mL) Unadjusted Model Final Model
R-squared = 0.681 p < 0.001
Variable b-Coefficient (95% CI) p-value b-Coefficient (95% CI) p-value
Lean Mass - Android (g) 0.29 (0.03, 0.55) 0.032 0.29 (0.03, 0.55) 0.032
Lean Mass - Gynoid (g) 0.3 (-0.1, 0.7) 0.082
%Sputum Eosinophils 19.67 (-6.24, 45.57) 0.125
Leptin (pg/mL) 0.025 (-0.002, 0.051) 0.063
Age (years) -28.2 (-51.2, -5.2) 0.019 -40.3 (-58.0, -22.7) < 0.001
Height (cm) 12.6 (-18.3, 43.5) 0.400 -9.5 (-40.8, 21.8) 0.529
FEV1/FVC Unadjusted Model Final Model
R-squared = 0.510 p <0.001
Variable b-Coefficient (95% CI) p-value b-Coefficient (95% CI) p-value
Lean Mass - Android (g) -0.006 (-0.012, -0.002) 0.014 -0.007 (-0.012, -0.002) 0.014
%Sputum Neutrophils 0.1 (-0.1, 0.3) 0.149
%Sputum Eosinophils -0.56 (-1.09, -0.03) 0.039 -0.6 (-1.0, -0.2) 0.009
CRP (pg/mL) -2.3 (-4.0, -0.6) 0.010
Age (years) -0.3 (-0.7, 0.2) 0.225 -0.2 (-0.6, 0.1) 0.141
ERV - expiratory reserve volume; FEV1 - forced expiratory volume in one second; FVC - forced vital capacity; CRP - C-reactive protein.
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lipids may provide further insight into the obese-
asthma association.
In contrast, we observed a positive association
between central (android and thoracic) lean mass and
static lung function in males. A number of DXA studies
have cited a similar relationship in healthy subjects
[6,33], with loss of lean mass an important predictor of
lung function decline in the elderly [12]. We found that
for every 100 g increase in android lean mass, there was
a corresponding increase in ERV of 29 mL. This finding
suggests an important role for central lean mass in pre-
serving static lung function in males. Surprisingly we
did not observe significant associations between fat
mass and lung function in males, nor was fat mass a sig-
nificant predictor of lung function in either of the
regression models. This is in contrast to females, for
whom fat mass was a considerable predictor of reduced
lung function. This supports previous research by
Sutherland et al [6] who also observed a greater effect
of adipose tissue on the lung function of females com-
pared with males. In contrast to the female subjects,
there was no association between neutrophilic airway
inflammation and body composition or lung function in
males. We did, however, observe a weak positive asso-
ciation between sputum eosinophils and fat mass in
males, while sputum eosinophils were a negative predic-
tor of FEV1/FVC. This result has not been previously
described and further examination of the role of eosino-
philic airway inflammation in overweight and obese
males may be warranted.
Simple anthropometric measurements such as body
weight or waist circumference alone do not accurately
describe body composition. We did not find body
weight or waist circumference to be significantly related
to dynamic or static lung function in males. We propose
that this may be due to the opposing effects that lean
mass and fat mass have on lung function and the fact
that body weight and waist measurement cannot discri-
minate between these two tissue types. In females, how-
ever, both body weight and waist circumference were
negatively associated with static lung function. These
findings suggest that if lung function prediction equa-
tions were to be adjusted for obesity, waist circumfer-
ence would be a suitable measure in females but not
males. This poses a problem in males, as more accurate
measures of body composition (i.e. those that quantify
lean mass) are not practical within the clinical setting.
A limitation of this trial is the limited sample size and
its cross-sectional nature which does not allow for the
establishment of causality. However, this study has gen-
erated some novel findings that extend existing knowl-
edge in the field and suggest an interesting direction for
future research. Another limitation is that DXA is not
able to differentiate between visceral and subcutaneous
fat, nor can it distinguish intramyocellular lipid from
lean tissue. More hazardous and expensive investiga-
tional techniques such as computerised tomography
(CT) and magnetic resonance imaging (MRI) would be
required to evaluate the importance of these measures
of fat distribution, however would be advantageous for
future trials. Finally, all subjects were within a limited
BMI range (28-40 kg/m
2) and as such these results can-
not necessarily be generalised to all individuals.
Conclusions
In conclusion, our data suggests that body composition
and systemic and airway inflammation independently
alter respiratory function and that these influences are
sexually dimorphic in nature. We found android and
upper body adiposity to be negatively associated with
lung function in females, whilst lean mass in the android
region was an important positive predictor of lung func-
tion in males. Our data also indicates that lean tissue is
Table 7 Multiple linear regression examining the relationship of body composition, airway inflammation and systemic
inflammation, with lung function in females.
ERV (mL) Unadjusted Model Final Model
R-squared = 0.569 p < 0.001
Variable b-Coefficient (95% CI) p-value b-Coefficient (95% CI) p-value
Fat Mass - Android (g) -0.20 (-0.39, -0.01) 0.037 -0.20 (-0.39, -0.01) 0.037
Lean Mass - Android (g) -0.24 (-0.58, 0.11) 0.173
Age (years) -20.7 (-30.7, -10.7) < 0.001 -16.0 (-25.0, -7.0) 0.001
Height (cm) 11.4 (-29.0, 51.8) 0.564 -29.5 (-15.6, 74.5) 0.188
FEV1/FVC Unadjusted Model Final Model
R-squared=0.264 p= 0.020
Variable b-Coefficient (95% CI) p-value b-Coefficient (95% CI) p-value
%Sputum Neutrophils -0.15 (-0.29, -0.05) 0.007 -0.13 (-0.23, -0.03) 0.012
Age (years) -0.3 (-0.5, -0.1) 0.010 -0.1 (-0.3, 0.2) 0.561
ERV - expiratory reserve volume; FEV1 - forced expiratory volume in one second; FVC - forced vital capacity.
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tion in females, however the mechanism driving this
association is uncertain. Lean tissue should be examined
in depth to elucidate how this tissue may be driving
neutrophilic airway inflammation and worsening lung
function in females with asthma. This study has docu-
mented an interplay between distribution of lean and fat
masses, airway and systemic inflammation and lung
function in overweight and obese asthma. Our findings
suggest that the worsened lung function known to be
associated with the obese-asthma phenotype is multifac-
torial in origin, involving an interplay between distribu-
tion of lean and fat masses. The findings of this study
also suggest that the obese-asthma phenotype is sexually
dimorphic in nature and therefore sex differences must
be considered in future trials. Future studies should
examine whether age of asthma onset modifies these
associations. Additional studies are needed to establish
the clinical relevance of these findings, to assist in the
management of overweight and obese asthma.
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